Lv1
56 积分 2025-07-29 加入
177a: FIRST-IN-CLASS ORAL TL1A NANOBODY AND LONG-ACTING TL1A/IL-23 BISPECIFIC NANOBODY: NOVEL THERAPIES FOR INFLAMMATORY BOWEL DISEASE
2天前
已关闭
Nanobodies for inflammatory bowel disease: Miniaturizing solutions
2天前
已完结
MARCO+ Tumor‐Associated Macrophages Impede CD8+ T Cell Immunity to Facilitate Immunotherapy Resistance in Renal Cell Carcinoma
4个月前
已完结
CCL19-producing fibroblasts promote tertiary lymphoid structure formation enhancing anti-tumor IgG response in colorectal cancer liver metastasis
5个月前
已完结
Rescuing Dendritic Cell Interstitial Motility Sustains Antitumor Immunity
5个月前
已关闭
The CD74 inhibitor DRhQ improves short-term memory and mitochondrial function in 5xFAD mouse model of Aβ accumulation
7个月前
已完结
De novo-designed pMHC binders facilitate T cell–mediated cytotoxicity toward cancer cells
7个月前
已完结
CHD7对发育和疾病的表观遗传调控研究进展
8个月前
已完结
Single-cell analysis reveals a stem-cell program in human metastatic breast cancer cells
8个月前
已完结
Mutation of CHD7 impairs the output of neuroepithelium transition that is reversed by the inhibition of EZH2
8个月前
已完结
皖公网安备34019202002308
